HEADER VIRAL PROTEIN 25-FEB-20 6Y5L TITLE SIGNAL SUBTRACTED EXTENDED INTERMEDIATE FORM OF X-31 INFLUENZA TITLE 2 HAEMAGGLUTININ AT PH 5 (STATE IV) COMPND MOL_ID: 1; COMPND 2 MOLECULE: X-31 INFLUENZA HAEMAGGLUTININ HA1,X-31 INFLUENZA COMPND 3 HAEMAGGLUTININ HA1; COMPND 4 CHAIN: A, C, E; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: X-31 INFLUENZA HAEMAGGLUTININ HA2; COMPND 8 CHAIN: B, D, F; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: UNIDENTIFIED INFLUENZA VIRUS; SOURCE 3 ORGANISM_TAXID: 11309; SOURCE 4 EXPRESSION_SYSTEM: GALLUS GALLUS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 9031; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: UNIDENTIFIED INFLUENZA VIRUS; SOURCE 8 ORGANISM_TAXID: 11309; SOURCE 9 EXPRESSION_SYSTEM: GALLUS GALLUS; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 9031 KEYWDS HAEMAGGLUTININ, HEMAGGLUTININ, FUSION PROTEIN, VIRAL PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR D.J.BENTON,P.B.ROSENTHAL REVDAT 3 29-JUL-20 6Y5L 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE REVDAT 2 15-JUL-20 6Y5L 1 JRNL REVDAT 1 10-JUN-20 6Y5L 0 JRNL AUTH D.J.BENTON,S.J.GAMBLIN,P.B.ROSENTHAL,J.J.SKEHEL JRNL TITL STRUCTURAL TRANSITIONS IN INFLUENZA HAEMAGGLUTININ AT JRNL TITL 2 MEMBRANE FUSION PH. JRNL REF NATURE V. 583 150 2020 JRNL REFN ESSN 1476-4687 JRNL PMID 32461688 JRNL DOI 10.1038/S41586-020-2333-6 REMARK 2 REMARK 2 RESOLUTION. 3.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : EPU, COOT, RELION, RELION, RELION, REMARK 3 CRYOSPARC, PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 2YPG REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.600 REMARK 3 NUMBER OF PARTICLES : 546000 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 6Y5L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-FEB-20. REMARK 100 THE DEPOSITION ID IS D_1292106954. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : X-31 INFLUENZA HAEMAGGLUTININ REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 1.25 REMARK 245 SAMPLE SUPPORT DETAILS : 25MA REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 5.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : FEI FALCON III (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 33.90 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 13510 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29970 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -112.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, E, D, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY B 1 REMARK 465 LEU B 2 REMARK 465 PHE B 3 REMARK 465 GLY B 4 REMARK 465 ALA B 5 REMARK 465 ILE B 6 REMARK 465 ALA B 7 REMARK 465 GLY B 8 REMARK 465 PHE B 9 REMARK 465 ILE B 10 REMARK 465 GLU B 11 REMARK 465 ASN B 12 REMARK 465 GLY B 13 REMARK 465 TRP B 14 REMARK 465 GLU B 15 REMARK 465 GLY B 16 REMARK 465 MET B 17 REMARK 465 ILE B 18 REMARK 465 ASP B 19 REMARK 465 GLY B 20 REMARK 465 TRP B 21 REMARK 465 TYR B 22 REMARK 465 GLY B 23 REMARK 465 PHE B 24 REMARK 465 ARG B 25 REMARK 465 HIS B 26 REMARK 465 GLN B 27 REMARK 465 ASN B 28 REMARK 465 SER B 29 REMARK 465 GLU B 30 REMARK 465 GLY B 31 REMARK 465 THR B 32 REMARK 465 GLY B 33 REMARK 465 GLN B 34 REMARK 465 ALA B 35 REMARK 465 ALA B 36 REMARK 465 LEU B 126 REMARK 465 ARG B 127 REMARK 465 GLU B 128 REMARK 465 ASN B 129 REMARK 465 ALA B 130 REMARK 465 GLU B 131 REMARK 465 GLU B 132 REMARK 465 MET B 133 REMARK 465 GLY B 134 REMARK 465 ASN B 135 REMARK 465 GLY B 136 REMARK 465 CYS B 137 REMARK 465 PHE B 138 REMARK 465 LYS B 139 REMARK 465 ILE B 140 REMARK 465 TYR B 141 REMARK 465 HIS B 142 REMARK 465 LYS B 143 REMARK 465 CYS B 144 REMARK 465 ASP B 145 REMARK 465 ASN B 146 REMARK 465 ALA B 147 REMARK 465 CYS B 148 REMARK 465 ILE B 149 REMARK 465 GLU B 150 REMARK 465 SER B 151 REMARK 465 ILE B 152 REMARK 465 ARG B 153 REMARK 465 ASN B 154 REMARK 465 GLY B 155 REMARK 465 THR B 156 REMARK 465 TYR B 157 REMARK 465 ASP B 158 REMARK 465 HIS B 159 REMARK 465 ASP B 160 REMARK 465 VAL B 161 REMARK 465 TYR B 162 REMARK 465 ARG B 163 REMARK 465 ASP B 164 REMARK 465 GLU B 165 REMARK 465 ALA B 166 REMARK 465 LEU B 167 REMARK 465 ASN B 168 REMARK 465 ASN B 169 REMARK 465 ARG B 170 REMARK 465 PHE B 171 REMARK 465 GLN B 172 REMARK 465 GLY D 1 REMARK 465 LEU D 2 REMARK 465 PHE D 3 REMARK 465 GLY D 4 REMARK 465 ALA D 5 REMARK 465 ILE D 6 REMARK 465 ALA D 7 REMARK 465 GLY D 8 REMARK 465 PHE D 9 REMARK 465 ILE D 10 REMARK 465 GLU D 11 REMARK 465 ASN D 12 REMARK 465 GLY D 13 REMARK 465 TRP D 14 REMARK 465 GLU D 15 REMARK 465 GLY D 16 REMARK 465 MET D 17 REMARK 465 ILE D 18 REMARK 465 ASP D 19 REMARK 465 GLY D 20 REMARK 465 TRP D 21 REMARK 465 TYR D 22 REMARK 465 GLY D 23 REMARK 465 PHE D 24 REMARK 465 ARG D 25 REMARK 465 HIS D 26 REMARK 465 GLN D 27 REMARK 465 ASN D 28 REMARK 465 SER D 29 REMARK 465 GLU D 30 REMARK 465 GLY D 31 REMARK 465 THR D 32 REMARK 465 GLY D 33 REMARK 465 GLN D 34 REMARK 465 ALA D 35 REMARK 465 ALA D 36 REMARK 465 LEU D 126 REMARK 465 ARG D 127 REMARK 465 GLU D 128 REMARK 465 ASN D 129 REMARK 465 ALA D 130 REMARK 465 GLU D 131 REMARK 465 GLU D 132 REMARK 465 MET D 133 REMARK 465 GLY D 134 REMARK 465 ASN D 135 REMARK 465 GLY D 136 REMARK 465 CYS D 137 REMARK 465 PHE D 138 REMARK 465 LYS D 139 REMARK 465 ILE D 140 REMARK 465 TYR D 141 REMARK 465 HIS D 142 REMARK 465 LYS D 143 REMARK 465 CYS D 144 REMARK 465 ASP D 145 REMARK 465 ASN D 146 REMARK 465 ALA D 147 REMARK 465 CYS D 148 REMARK 465 ILE D 149 REMARK 465 GLU D 150 REMARK 465 SER D 151 REMARK 465 ILE D 152 REMARK 465 ARG D 153 REMARK 465 ASN D 154 REMARK 465 GLY D 155 REMARK 465 THR D 156 REMARK 465 TYR D 157 REMARK 465 ASP D 158 REMARK 465 HIS D 159 REMARK 465 ASP D 160 REMARK 465 VAL D 161 REMARK 465 TYR D 162 REMARK 465 ARG D 163 REMARK 465 ASP D 164 REMARK 465 GLU D 165 REMARK 465 ALA D 166 REMARK 465 LEU D 167 REMARK 465 ASN D 168 REMARK 465 ASN D 169 REMARK 465 ARG D 170 REMARK 465 PHE D 171 REMARK 465 GLN D 172 REMARK 465 GLY F 1 REMARK 465 LEU F 2 REMARK 465 PHE F 3 REMARK 465 GLY F 4 REMARK 465 ALA F 5 REMARK 465 ILE F 6 REMARK 465 ALA F 7 REMARK 465 GLY F 8 REMARK 465 PHE F 9 REMARK 465 ILE F 10 REMARK 465 GLU F 11 REMARK 465 ASN F 12 REMARK 465 GLY F 13 REMARK 465 TRP F 14 REMARK 465 GLU F 15 REMARK 465 GLY F 16 REMARK 465 MET F 17 REMARK 465 ILE F 18 REMARK 465 ASP F 19 REMARK 465 GLY F 20 REMARK 465 TRP F 21 REMARK 465 TYR F 22 REMARK 465 GLY F 23 REMARK 465 PHE F 24 REMARK 465 ARG F 25 REMARK 465 HIS F 26 REMARK 465 GLN F 27 REMARK 465 ASN F 28 REMARK 465 SER F 29 REMARK 465 GLU F 30 REMARK 465 GLY F 31 REMARK 465 THR F 32 REMARK 465 GLY F 33 REMARK 465 GLN F 34 REMARK 465 ALA F 35 REMARK 465 ALA F 36 REMARK 465 LEU F 126 REMARK 465 ARG F 127 REMARK 465 GLU F 128 REMARK 465 ASN F 129 REMARK 465 ALA F 130 REMARK 465 GLU F 131 REMARK 465 GLU F 132 REMARK 465 MET F 133 REMARK 465 GLY F 134 REMARK 465 ASN F 135 REMARK 465 GLY F 136 REMARK 465 CYS F 137 REMARK 465 PHE F 138 REMARK 465 LYS F 139 REMARK 465 ILE F 140 REMARK 465 TYR F 141 REMARK 465 HIS F 142 REMARK 465 LYS F 143 REMARK 465 CYS F 144 REMARK 465 ASP F 145 REMARK 465 ASN F 146 REMARK 465 ALA F 147 REMARK 465 CYS F 148 REMARK 465 ILE F 149 REMARK 465 GLU F 150 REMARK 465 SER F 151 REMARK 465 ILE F 152 REMARK 465 ARG F 153 REMARK 465 ASN F 154 REMARK 465 GLY F 155 REMARK 465 THR F 156 REMARK 465 TYR F 157 REMARK 465 ASP F 158 REMARK 465 HIS F 159 REMARK 465 ASP F 160 REMARK 465 VAL F 161 REMARK 465 TYR F 162 REMARK 465 ARG F 163 REMARK 465 ASP F 164 REMARK 465 GLU F 165 REMARK 465 ALA F 166 REMARK 465 LEU F 167 REMARK 465 ASN F 168 REMARK 465 ASN F 169 REMARK 465 ARG F 170 REMARK 465 PHE F 171 REMARK 465 GLN F 172 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS A 27 OE2 GLU B 97 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 22 59.27 -94.80 REMARK 500 ALA A 39 -175.72 179.74 REMARK 500 ALA A 317 127.94 -35.50 REMARK 500 ASN C 22 59.29 -94.82 REMARK 500 ALA C 39 -175.76 179.74 REMARK 500 ALA C 317 127.92 -35.43 REMARK 500 ASN E 22 59.27 -94.76 REMARK 500 ALA E 39 -175.73 179.74 REMARK 500 ALA E 317 127.94 -35.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-10701 RELATED DB: EMDB REMARK 900 SIGNAL SUBTRACTED EXTENDED INTERMEDIATE FORM OF X-31 INFLUENZA REMARK 900 HAEMAGGLUTININ AT PH 5 (STATE IV) DBREF1 6Y5L A 19 43 UNP A0A286RZR2_9INFA DBREF2 6Y5L A A0A286RZR2 35 59 DBREF 6Y5L A 281 325 UNP P04663 HEMA_I70A0 281 325 DBREF 6Y5L B 1 172 UNP P03437 HEMA_I68A0 346 517 DBREF1 6Y5L C 19 43 UNP A0A286RZR2_9INFA DBREF2 6Y5L C A0A286RZR2 35 59 DBREF 6Y5L C 281 325 UNP P04663 HEMA_I70A0 281 325 DBREF1 6Y5L E 19 43 UNP A0A286RZR2_9INFA DBREF2 6Y5L E A0A286RZR2 35 59 DBREF 6Y5L E 281 325 UNP P04663 HEMA_I70A0 281 325 DBREF 6Y5L D 1 172 UNP P03437 HEMA_I68A0 346 517 DBREF 6Y5L F 1 172 UNP P03437 HEMA_I68A0 346 517 SEQRES 1 A 70 ALA VAL PRO ASN GLY THR LEU VAL LYS THR ILE THR ASP SEQRES 2 A 70 ASP GLN ILE GLU VAL THR ASN ALA THR GLU LEU VAL CYS SEQRES 3 A 70 ILE THR PRO ASN GLY SER ILE PRO ASN ASP LYS PRO PHE SEQRES 4 A 70 GLN ASN VAL ASN LYS ILE THR TYR GLY ALA CYS PRO LYS SEQRES 5 A 70 TYR VAL LYS GLN ASN THR LEU LYS LEU ALA THR GLY MET SEQRES 6 A 70 ARG ASN VAL PRO GLU SEQRES 1 B 172 GLY LEU PHE GLY ALA ILE ALA GLY PHE ILE GLU ASN GLY SEQRES 2 B 172 TRP GLU GLY MET ILE ASP GLY TRP TYR GLY PHE ARG HIS SEQRES 3 B 172 GLN ASN SER GLU GLY THR GLY GLN ALA ALA ASP LEU LYS SEQRES 4 B 172 SER THR GLN ALA ALA ILE ASP GLN ILE ASN GLY LYS LEU SEQRES 5 B 172 ASN ARG VAL ILE GLU LYS THR ASN GLU LYS PHE HIS GLN SEQRES 6 B 172 ILE GLU LYS GLU PHE SER GLU VAL GLU GLY ARG ILE GLN SEQRES 7 B 172 ASP LEU GLU LYS TYR VAL GLU ASP THR LYS ILE ASP LEU SEQRES 8 B 172 TRP SER TYR ASN ALA GLU LEU LEU VAL ALA LEU GLU ASN SEQRES 9 B 172 GLN HIS THR ILE ASP LEU THR ASP SER GLU MET ASN LYS SEQRES 10 B 172 LEU PHE GLU LYS THR ARG ARG GLN LEU ARG GLU ASN ALA SEQRES 11 B 172 GLU GLU MET GLY ASN GLY CYS PHE LYS ILE TYR HIS LYS SEQRES 12 B 172 CYS ASP ASN ALA CYS ILE GLU SER ILE ARG ASN GLY THR SEQRES 13 B 172 TYR ASP HIS ASP VAL TYR ARG ASP GLU ALA LEU ASN ASN SEQRES 14 B 172 ARG PHE GLN SEQRES 1 C 70 ALA VAL PRO ASN GLY THR LEU VAL LYS THR ILE THR ASP SEQRES 2 C 70 ASP GLN ILE GLU VAL THR ASN ALA THR GLU LEU VAL CYS SEQRES 3 C 70 ILE THR PRO ASN GLY SER ILE PRO ASN ASP LYS PRO PHE SEQRES 4 C 70 GLN ASN VAL ASN LYS ILE THR TYR GLY ALA CYS PRO LYS SEQRES 5 C 70 TYR VAL LYS GLN ASN THR LEU LYS LEU ALA THR GLY MET SEQRES 6 C 70 ARG ASN VAL PRO GLU SEQRES 1 E 70 ALA VAL PRO ASN GLY THR LEU VAL LYS THR ILE THR ASP SEQRES 2 E 70 ASP GLN ILE GLU VAL THR ASN ALA THR GLU LEU VAL CYS SEQRES 3 E 70 ILE THR PRO ASN GLY SER ILE PRO ASN ASP LYS PRO PHE SEQRES 4 E 70 GLN ASN VAL ASN LYS ILE THR TYR GLY ALA CYS PRO LYS SEQRES 5 E 70 TYR VAL LYS GLN ASN THR LEU LYS LEU ALA THR GLY MET SEQRES 6 E 70 ARG ASN VAL PRO GLU SEQRES 1 D 172 GLY LEU PHE GLY ALA ILE ALA GLY PHE ILE GLU ASN GLY SEQRES 2 D 172 TRP GLU GLY MET ILE ASP GLY TRP TYR GLY PHE ARG HIS SEQRES 3 D 172 GLN ASN SER GLU GLY THR GLY GLN ALA ALA ASP LEU LYS SEQRES 4 D 172 SER THR GLN ALA ALA ILE ASP GLN ILE ASN GLY LYS LEU SEQRES 5 D 172 ASN ARG VAL ILE GLU LYS THR ASN GLU LYS PHE HIS GLN SEQRES 6 D 172 ILE GLU LYS GLU PHE SER GLU VAL GLU GLY ARG ILE GLN SEQRES 7 D 172 ASP LEU GLU LYS TYR VAL GLU ASP THR LYS ILE ASP LEU SEQRES 8 D 172 TRP SER TYR ASN ALA GLU LEU LEU VAL ALA LEU GLU ASN SEQRES 9 D 172 GLN HIS THR ILE ASP LEU THR ASP SER GLU MET ASN LYS SEQRES 10 D 172 LEU PHE GLU LYS THR ARG ARG GLN LEU ARG GLU ASN ALA SEQRES 11 D 172 GLU GLU MET GLY ASN GLY CYS PHE LYS ILE TYR HIS LYS SEQRES 12 D 172 CYS ASP ASN ALA CYS ILE GLU SER ILE ARG ASN GLY THR SEQRES 13 D 172 TYR ASP HIS ASP VAL TYR ARG ASP GLU ALA LEU ASN ASN SEQRES 14 D 172 ARG PHE GLN SEQRES 1 F 172 GLY LEU PHE GLY ALA ILE ALA GLY PHE ILE GLU ASN GLY SEQRES 2 F 172 TRP GLU GLY MET ILE ASP GLY TRP TYR GLY PHE ARG HIS SEQRES 3 F 172 GLN ASN SER GLU GLY THR GLY GLN ALA ALA ASP LEU LYS SEQRES 4 F 172 SER THR GLN ALA ALA ILE ASP GLN ILE ASN GLY LYS LEU SEQRES 5 F 172 ASN ARG VAL ILE GLU LYS THR ASN GLU LYS PHE HIS GLN SEQRES 6 F 172 ILE GLU LYS GLU PHE SER GLU VAL GLU GLY ARG ILE GLN SEQRES 7 F 172 ASP LEU GLU LYS TYR VAL GLU ASP THR LYS ILE ASP LEU SEQRES 8 F 172 TRP SER TYR ASN ALA GLU LEU LEU VAL ALA LEU GLU ASN SEQRES 9 F 172 GLN HIS THR ILE ASP LEU THR ASP SER GLU MET ASN LYS SEQRES 10 F 172 LEU PHE GLU LYS THR ARG ARG GLN LEU ARG GLU ASN ALA SEQRES 11 F 172 GLU GLU MET GLY ASN GLY CYS PHE LYS ILE TYR HIS LYS SEQRES 12 F 172 CYS ASP ASN ALA CYS ILE GLU SER ILE ARG ASN GLY THR SEQRES 13 F 172 TYR ASP HIS ASP VAL TYR ARG ASP GLU ALA LEU ASN ASN SEQRES 14 F 172 ARG PHE GLN HET NAG A 401 14 HET NAG C 401 14 HET NAG E 401 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE FORMUL 7 NAG 3(C8 H15 N O6) HELIX 1 AA1 LEU B 38 GLN B 125 1 88 HELIX 2 AA2 LEU D 38 GLN D 125 1 88 HELIX 3 AA3 LEU F 38 GLN F 125 1 88 SHEET 1 AA1 2 THR A 24 VAL A 26 0 SHEET 2 AA1 2 ILE A 34 VAL A 36 -1 O VAL A 36 N THR A 24 SHEET 1 AA2 2 ILE A 282 THR A 283 0 SHEET 2 AA2 2 GLY A 286 SER A 287 -1 O GLY A 286 N THR A 283 SHEET 1 AA3 2 PHE A 294 GLN A 295 0 SHEET 2 AA3 2 LYS A 307 TYR A 308 1 O LYS A 307 N GLN A 295 SHEET 1 AA4 2 THR C 24 VAL C 26 0 SHEET 2 AA4 2 ILE C 34 VAL C 36 -1 O VAL C 36 N THR C 24 SHEET 1 AA5 2 ILE C 282 THR C 283 0 SHEET 2 AA5 2 GLY C 286 SER C 287 -1 O GLY C 286 N THR C 283 SHEET 1 AA6 2 PHE C 294 GLN C 295 0 SHEET 2 AA6 2 LYS C 307 TYR C 308 1 O LYS C 307 N GLN C 295 SHEET 1 AA7 2 THR E 24 VAL E 26 0 SHEET 2 AA7 2 ILE E 34 VAL E 36 -1 O VAL E 36 N THR E 24 SHEET 1 AA8 2 ILE E 282 THR E 283 0 SHEET 2 AA8 2 GLY E 286 SER E 287 -1 O GLY E 286 N THR E 283 SHEET 1 AA9 2 PHE E 294 GLN E 295 0 SHEET 2 AA9 2 LYS E 307 TYR E 308 1 O LYS E 307 N GLN E 295 SSBOND 1 CYS A 281 CYS A 305 1555 1555 2.03 SSBOND 2 CYS C 281 CYS C 305 1555 1555 2.03 SSBOND 3 CYS E 281 CYS E 305 1555 1555 2.03 LINK ND2 ASN A 38 C1 NAG A 401 1555 1555 1.44 LINK ND2 ASN C 38 C1 NAG C 401 1555 1555 1.44 LINK ND2 ASN E 38 C1 NAG E 401 1555 1555 1.44 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000